Sebastian Ochsenreither

11PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 24, 2025
Independent Validation of a Machine Learning Classifier for Predicting Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer Using Routinely Obtainable [18F]FDG-PET/CT Parameters.

Agata Wdowiak, Julian M M Rogasch, Georg L Baumgärtner

|Sep 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.

Takami Sato, Marcus O Butler, Sophie Piperno-Neumann

|Jun 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer.

Erika Zuljan, Benjamin von der Emde, Iris Piwonski

|Oct 15, 2024
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study.

Erika Hamilton, Matthew D Galsky, Sebastian Ochsenreither

|Oct 10, 2024
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer.

Eric Van Cutsem, Joelle Collignon, Rikke L Eefsen

|Mar 16, 2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro

Pageof 2

Frequent Collaborators

4 joint publications

Stefan Fröhling

3 joint publications

Melanie Boerries

3 joint publications

Ulrich Keller

3 joint publications

Damian T Rieke